Classical Hodgkin Lymphoma Overview
Learn About Classical Hodgkin Lymphoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Bret Cook is a Hematologist Oncology specialist and an Oncologist in Coos Bay, Oregon. Dr. Cook and is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Hemochromatosis, and Bone Marrow Aspiration. Dr. Cook is currently accepting new patients.
Bay Area Hospital District
Kathryn Richert-Boe is a Hematologist Oncology specialist and a Hematologist in Coos Bay, Oregon. Dr. Richert-Boe and is rated as an Advanced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Pleuropulmonary Blastoma, and Prostatectomy. Dr. Richert-Boe is currently accepting new patients.
Bay Area Hospital District
Douglas Rovira is a Hematologist Oncology specialist and an Oncologist in Coos Bay, Oregon. Dr. Rovira and is rated as an Experienced provider by MediFind in the treatment of Classical Hodgkin Lymphoma. His top areas of expertise are Primary Amyloidosis, Pleuropulmonary Blastoma, Lung Cancer, and Paget Disease of the Breast. Dr. Rovira is currently accepting new patients.
Summary: The primary purpose of the study is to assess the pharmacokinetics (PK) profile of pembrolizumab following subcutaneous (SC) injection of pembrolizumab coformulated with hyaluronidase, and to evaluate the objective response rate (ORR) of pembrolizumab (+) berahyaluronidase alfa SC in adult participants with Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary...
Summary: This study is being done to determine if two new drugs can shrink or eliminate classical Hodgkins lymphoma.